Equities analysts predict that Wright Medical Group NV (NASDAQ:WMGI) will report ($0.07) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Fifteen analysts have issued estimates for Wright Medical Group’s earnings, with the highest EPS estimate coming in at ($0.02) and the lowest estimate coming in at ($0.10). Wright Medical Group also posted earnings of ($0.07) per share during the same quarter last year. The business is scheduled to announce its next earnings report on Wednesday, August 1st.
According to Zacks, analysts expect that Wright Medical Group will report full-year earnings of ($0.14) per share for the current financial year, with EPS estimates ranging from ($0.24) to ($0.02). For the next year, analysts expect that the firm will report earnings of $0.17 per share, with EPS estimates ranging from ($0.08) to $0.38. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that follow Wright Medical Group.
Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, May 9th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.06. Wright Medical Group had a negative return on equity of 2.58% and a negative net margin of 22.11%. The firm had revenue of $198.54 million for the quarter, compared to analyst estimates of $193.69 million. During the same quarter last year, the company posted ($0.09) earnings per share. The business’s revenue was up 12.0% on a year-over-year basis.
A number of equities analysts recently issued reports on the company. Guggenheim raised Wright Medical Group from a “neutral” rating to a “buy” rating in a report on Wednesday. ValuEngine upgraded shares of Wright Medical Group from a “sell” rating to a “hold” rating in a research report on Tuesday, May 29th. BidaskClub upgraded shares of Wright Medical Group from a “sell” rating to a “hold” rating in a research report on Monday, May 14th. Oppenheimer set a $25.00 price objective on shares of Wright Medical Group and gave the company a “hold” rating in a research report on Thursday, May 10th. Finally, BMO Capital Markets reduced their price objective on shares of Wright Medical Group from $28.00 to $25.00 and set an “outperform” rating for the company in a research report on Wednesday, February 28th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $29.38.
In other news, insider Kevin D. Cordell sold 2,738 shares of Wright Medical Group stock in a transaction that occurred on Monday, June 4th. The shares were sold at an average price of $24.62, for a total transaction of $67,409.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Julie Andrews sold 1,466 shares of Wright Medical Group stock in a transaction that occurred on Monday, June 4th. The shares were sold at an average price of $24.62, for a total transaction of $36,092.92. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,768 shares of company stock valued at $338,324. 4.00% of the stock is owned by insiders.
Hedge funds have recently bought and sold shares of the company. Swiss National Bank lifted its position in shares of Wright Medical Group by 1.9% during the 4th quarter. Swiss National Bank now owns 167,094 shares of the medical device company’s stock valued at $3,709,000 after acquiring an additional 3,100 shares during the period. Comgest Global Investors S.A.S. acquired a new stake in shares of Wright Medical Group during the 4th quarter valued at approximately $1,991,000. Iguana Healthcare Management LLC acquired a new stake in shares of Wright Medical Group during the 4th quarter valued at approximately $444,000. Endurant Capital Management LP lifted its position in shares of Wright Medical Group by 670.7% during the 4th quarter. Endurant Capital Management LP now owns 305,200 shares of the medical device company’s stock valued at $6,775,000 after acquiring an additional 265,600 shares during the period. Finally, Palo Alto Investors LLC lifted its position in shares of Wright Medical Group by 2.2% during the 4th quarter. Palo Alto Investors LLC now owns 2,736,293 shares of the medical device company’s stock valued at $60,746,000 after acquiring an additional 59,900 shares during the period.
Shares of NASDAQ WMGI traded up $0.32 during midday trading on Friday, reaching $26.10. 1,526,500 shares of the company were exchanged, compared to its average volume of 1,090,689. The company has a quick ratio of 0.95, a current ratio of 1.42 and a debt-to-equity ratio of 1.46. Wright Medical Group has a 1 year low of $19.01 and a 1 year high of $29.89. The firm has a market cap of $2.65 billion, a P/E ratio of -118.59 and a beta of 0.78.
Wright Medical Group Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.